Evidence-based opioid prescribing guidelines after lung resection: a prospective, multicenter analysis

  • Jarred R. Mondoñedo
  • , Alexander A. Brescia
  • , Melissa J. Clark
  • , Matthew L. Chang
  • , Shannon Jiang
  • , Chang He
  • , Robert J. Welsh
  • , Andrew M. Popoff
  • , Mohan G. Kulkarni
  • , Shelly C. Lall
  • , Jerry W. Pratt
  • , Kumari N. Adams
  • , Raed M. Alnajjar
  • , James R. Martin
  • , Divyakant B. Gandhi
  • , Chad M. Brummett
  • , Andrew C. Chang
  • , Kiran H. Lagisetty

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Background: Opioid prescribing guidelines have significantly decreased overprescribing and post-discharge use after cardiac surgery; however, limited recommendations exist for general thoracic surgery patients, a similarly high-risk population. We examined opioid prescribing and patient-reported use to develop evidence-based, opioid prescribing guidelines after lung cancer resection. Methods: This prospective, statewide, quality improvement study was conducted between January 2020 to March 2021 and included patients undergoing surgical resection of a primary lung cancer across 11 institutions. Patient-reported outcomes at 1-month follow-up were linked with clinical data and Society of Thoracic Surgery (STS) database records to characterize prescribing patterns and post-discharge use. The primary outcome was quantity of opioid used after discharge; secondary outcomes included quantity of opioid prescribed at discharge and patient-reported pain scores. Opioid quantities are reported in number of 5-mg oxycodone tablets (mean ± standard deviation). Results: Of the 602 patients identified, 429 met inclusion criteria. Questionnaire response rate was 65.0%. At discharge, 83.4% of patients were provided a prescription for opioids of mean size 20.5±13.1 pills, while patients reported using 8.2±13.0 pills after discharge (P<0.001), including 43.7% who used none. Those not taking opioids on the calendar day prior to discharge (32.4%) used fewer pills (4.4±8.1 vs. 11.7±14.9, P<0.001). Refill rate was 21.5% for patients provided a prescription at discharge, while 12.5% of patients not prescribed opioids at discharge required a new prescription before follow-up. Pain scores were 2.4±2.5 for incision site and 3.0±2.8 for overall pain (scale 0–10). Conclusions: Patient-reported post-discharge opioid use, surgical approach, and in-hospital opioid use before discharge should be used to inform prescribing recommendations after lung resection.

Original languageEnglish
Pages (from-to)3285-3294
Number of pages10
JournalJournal of Thoracic Disease
Volume15
Issue number6
DOIs
StatePublished - Jun 2023

Keywords

  • lung cancer
  • Opioid prescribing
  • practice guidelines
  • thoracic surgery

Fingerprint

Dive into the research topics of 'Evidence-based opioid prescribing guidelines after lung resection: a prospective, multicenter analysis'. Together they form a unique fingerprint.

Cite this